Home > Compound List > Product Information
Diosmin_Molecular_structure_CAS_520-27-4)
Click picture or here to close

Diosmin

Catalog No. Bio-0841 Name InterBioScreen
CAS Number 520-27-4 Website http://www.ibscreen.com
M. F. C28H32O15 Telephone +7 49652 40091
M. W. 608.54468 Fax
Purity Email screen@ibscreen.chg.ru
Storage Chembase ID: 72938

SYNONYMS

IUPAC name
5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one
IUPAC Traditional name
5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one
Synonyms
Daflon
Barosmin;
Diosmetin 7-rutinoside
Ven-Detrex
Salinigricoflavonoloside

DATABASE IDS

CAS Number 520-27-4

PROPERTIES

Application(s) Bioflavonoid
Application(s) Antihaemorrhagic
Application(s) Venotonic
Biological Source Isol. from Zanthoxylum avicennae, Diosma crenulata and others, first isol. from parsley
Mechanism of Action Reduces the expression of endothelial adhesion molecules (ICAM1, VCAM1), and inhibits the adhesion, migration, and activation of leukocytes at the capillary level.
Mechanism of Action This leads to a reduction in the release of inflammatory mediators, principally oxygen free radicals and prostaglandins (PGE2, PGF2a).

DETAILS

REFERENCES

  • Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 98C, (ir)
  • Lovecy, A. et al., J.C.S., 1930, 817, (synth)
  • Arthur, H.R. et al., J.C.S., 1956, 632, (Diosmin)
  • Horowitz, R.M. et al., J.O.C., 1956, 21, 1184, (isol)
  • Booth, A.N. et al., J. Biol. Chem., 1958, 230, 661, (metab)
  • Rsler, H. et al., J.O.C., 1965, 30, 4346, (pmr)
  • Plouvier, V., C. R. Hebd. Seances Acad. Sci. Ser. D, 1966, 263, 439, (isol, struct)
  • Brieskorn, C.H. et al., Arch. Pharm. (Weinheim, Ger.), 1971, 304, 557, (isol)
  • Wagner, H. et al., Tet. Lett., 1976, 1799, (cmr)
  • Oustrin, J. et al., Arzneim.-Forsch., 1977, 27, 1688, (pharmacol)
  • Le Quesne, P.W. et al., J.C.S. Perkin 1, 1978, 1572, (isol, uv, pmr)
  • Itokawa, H. et al., Chem. Lett., 1982, 1, 49, (ms)
  • Fujita, M. et al., Chem. Pharm. Bull., 1982, 30, 1151, (cmr)
  • Martindale, The Extra Pharmacopoeia, 28th/29th edn., Pharmaceutical Press, 1982, 12667
  • Voigtlnder, H.W. et al., Arch. Pharm. (Weinheim, Ger.), 1983, 316, 219, (synth)
  • Voirin, B., Phytochemistry, 1983, 22, 2107, (uv)
  • Rashid, M.A. et al., Fitoterapia, 1995, 66, 471, (Diosmin, pmr, cmr)
  • Bergan, J.J. et al., Angiology, 2001, 52, S43-S47, (diosmin, rev)
  • Garner, R.C. et al., J. Pharm. Sci., 2002, 91, 32-40, (diosmin, pharmacol)